LENZ Therapeutics's three largest insider shareholders as of March 23, 2026 are Venture Capital Vi, L.P. Versant (TenPercentOwner, 1.81Mn shares), Davis Jerel (Director, 1.71Mn shares), James W Mccollum (Director, 525.57K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Venture Capital Vi, L.P. Versant | 1,050,599 | 764,127 | 02 Oct, 2025 | |
| Davis Jerel | 0 | 1,707,719 | 01 Jul, 2021 | |
| James W Mccollum | 0 | 525,565 | 14 May, 2024 | |
| Phil Gutry | Chief Business Officer | 299,941 | 0 | 13 Apr, 2022 |
| Marc Odrich | Chief Medical Officer | 99,599 | 0 | 25 Mar, 2024 |
| Evert B. Schimmelpennink | President, Ceo And Secretary | 49,200 | 0 | 07 Mar, 2025 |
| Biocapital, L.P. Samsara | 0 | 37,753 | 01 Jul, 2021 | |
| James W Mccollum | 10,500 | 0 | 10 Nov, 2025 | |
| Daniel R. Chevallard | Chief Financial Officer | 5,386 | 0 | 07 Nov, 2025 |
| Shawn Olsson | Chief Commercial Officer | 4,733 | 0 | 19 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Shawn Olsson | Stock Option (right to buy) | A | 84,200 | $0.00 | 84,200 | D | A |
| 02 Jan, 2026 | Marc Odrich | Stock Option (right to buy) | A | 84,200 | $0.00 | 84,200 | D | A |
| 02 Jan, 2026 | Evert B. Schimmelpennink | Stock Option (right to buy) | A | 358,100 | $0.00 | 358,100 | D | A |
| 02 Jan, 2026 | Daniel R. Chevallard | Stock Option (right to buy) | A | 84,200 | $0.00 | 84,200 | D | A |
| 02 Jan, 2026 | Shawn Olsson | Restricted Stock Unit | A | 14,000 | $0.00 | 14,000 | D | A |
| 02 Jan, 2026 | Marc Odrich | Restricted Stock Unit | A | 14,000 | $0.00 | 14,000 | D | A |
| 02 Jan, 2026 | Daniel R. Chevallard | Restricted Stock Unit | A | 14,000 | $0.00 | 14,000 | D | A |
| 17 Nov, 2025 | Shawn Olsson | Common Stock | A | 10,000 | $2.08 | 14,733 | D | M |
| 17 Nov, 2025 | Shawn Olsson | Common Stock | D | 4,212 | $25.74 | 10,521 | D | S |
| 17 Nov, 2025 | Shawn Olsson | Common Stock | D | 5,788 | $26.37 | 4,733 | D | S |
| 17 Nov, 2025 | Shawn Olsson | Stock Option (right to buy) | D | 10,000 | $0.00 | 53,241 | D | M |
| 07 Nov, 2025 | James W Mccollum | Common Stock | A | 10,500 | $22.79 | 10,500 | D | P |
| 07 Nov, 2025 | Daniel R. Chevallard | Common Stock | A | 20 | $22.71 | 3,208 | D | P |
| 07 Nov, 2025 | Daniel R. Chevallard | Common Stock | A | 2,178 | $22.76 | 5,386 | D | P |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 49,701 | $45.35 | 1,133,842 | D | S |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 34,405 | $45.35 | 821,752 | I | S |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 83,066 | $46.41 | 1,050,776 | D | S |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 57,502 | $46.41 | 764,250 | I | S |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 177 | $47.01 | 1,050,599 | D | S |
| 30 Sep, 2025 | Venture Capital Vi, L.P. Versant | Common Stock | D | 123 | $47.01 | 764,127 | I | S |